CMT Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-7,985
Closed -$1.86M 199
2016
Q4
$1.68M Buy
+7,985
New +$1.65M 0.08% 122
2016
Q1
Sell
-10,702
Closed -$3.06M 234
2015
Q4
$3.34M Buy
+10,702
New +$3.19M 0.17% 111

Other funds holding AGN

CMT Asset Management's AGN Position: Q1 2017 in Review

CMT Asset Management sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 7,985 shares — an estimated $1.86M sold.

CMT Asset Management first reported a position in AGN in Q4 2015 and held it in 2 quarters. The position peaked at $3.34M in Q4 2015. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • CMT Asset Management reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • CMT Asset Management sold 7,985 Allergan plc shares in Q1 2017, an estimated $1.86M.
  • CMT Asset Management first reported a position in Allergan plc in Q4 2015 and held it in 2 quarters.
  • CMT Asset Management's Allergan plc position peaked at $3.34M in Q4 2015.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on CMT Asset Management's 13F filing for Q1 2017, filed 15 May 2017.